(Q40761230)

English

Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

Eva-Bettina Bröcker

7

object named as

Eva-B Bröcker

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Jürgen C Becker

2

object named as

Jürgen C Becker

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Eckhart Kämpgen

8

object named as

Eckhart Kämpgen

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Andreas A O Eggert

1

object named as

Andreas O Eggert

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Michael Ammon

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Alexander D McLellan

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

German Renner

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Angela Merkel

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

122-127

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Human tumor antigens for cancer vaccine development

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Specific separation of cytotoxic T lymphocytes on immunoadsorptive films

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C122%3A%3AAID-IMMU122%3E3.0.CO%3B2-C

21 January 2018

Identifiers

10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO;2-C

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

release_5tt7ecbkmrctncffrhvyvvvsde

1 reference

https://api.fatcat.wiki/v0/release/5tt7ecbkmrctncffrhvyvvvsde

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40761230&oldid=1906748315"